‘Intensive’ blood pressure treatment could reduce dementia risk: study
The study found that intensive blood pressure treatment may help to clear toxins and other byproducts from the brain.
Proposed Massachusetts bill would reduce inmate sentences if they donate organs
If passed, eligible individuals who are behind bars in Massachusetts could receive 60 days to one year off of their sentences in exchange for donating organs or bone marrow.
New Alzheimer's drug: What to know as Leqembi hits the market
Here are some things to know about the FDA's approval of lecanemab, to be sold under the brand name Leqembi.
FDA changes Plan B label, says emergency contraceptive won't cause abortion
The new labels are intended to further distinguish emergency contraception — also known as the morning after pill — from abortion pills.
Unemployment benefits and Obamacare subsidies outpace median income in several states, study finds
The labor force participation rate was 62.1% last month, notably lower than the 63.4% mark it was at before the coronavirus pandemic struck the United States in March 2020.
US home births in 2021 rose to highest level in decades, CDC report says
Among almost 4 million U.S. births in 2021, nearly 52,000 occurred at home — an increase of about 12% from the previous year, the CDC said.
Blood pressure medication recalled due to chemicals' possible link to cancer
The FDA-recalled quinapril and hydrochlorothiazide tablets were shipped to customers nationwide in May 2021.
Replacement effort for sleep apnea device recall expected to drag into 2023, fueling frustration
Philips initially estimated it could repair or replace the units within a year. But with the recall expanding to more than 5 million devices, it now says the effort will stretch into next year.
New COVID subvariants are resisting immunity and treatments. Should you be worried?
Emerging Omicron subvariants XBB, BQ.1, and BQ1.1 are likely resistant to some of the top drugs used to treat COVID-19 infections, experts warn.
Diabetes-related weight loss drugs facing supply issues amid viral trend
Recently, billionaire Elon Musk admitted to using Wegovy to help him lose weight.
Pfizer says COVID-19 vaccine will cost $110-$130 per dose
Pfizer said the commercial pricing for adult COVID-19 vaccine doses could start in early 2023, depending on when the U.S. government phases out its program of buying the shots.
Cheaper, over-the-counter hearing aids now available in US stores
Several U.S. retailers are now selling over-the-counter hearing aids at a cheaper cost compared to prescription devices, officials say. Here’s where to buy them.
FDA confirms widespread shortage of Adderall in the US
The largest U.S. manufacturer Adderall, a prescription drug used primarily to treat ADHD, has been experiencing “ongoing intermittent manufacturing delays,” the FDA said.
US caregiver shortage impacting 65 and older population
There's a shortage of elderly caregivers, and finding enough is only getting harder.
Doctor burnout reached 'highest level on record' during COVID, experts want action
After physician burnout spiked during the COVID pandemic, experts see an urgent need to address the issue.
CDC says universal masking no longer recommended inside some hospitals, nursing homes
The CDC has eased its universal masking recommendations for some health care facilities — unless they’re located in areas of high COVID-19 transmission.
Doctors remove 50 large batteries from woman’s stomach, colon
Swallowing batteries is a “rare method of deliberate self-harm” that can cause serious complications.
FDA OKs Daxxify, an anti-wrinkle injection and Botox competitor
Studies showed the Daxxify drug can temporarily improve moderate to severe frown lines in adults for a median duration of about six months, according to the company.
Philips recalls 17M CPAP, BiPAP masks over magnets that could affect implanted devices
The mask recall was announced after 14 serious injuries were reported, including pacemaker failure, arrhythmia, seizures, and irregular blood pressure, the FDA said.
Lyme disease vaccine: 1st potential shot in 20 years enters late-stage trial
The only prior Lyme vaccine for people, made by another company, was pulled off the U.S. market in 2002.